Wednesday, February 8, 2023
For any kind of suggestion or query feel free to mail us at hello@globaldaily.in   Your online source for any kind of news   Welcome to Global Daily
GSK Pharma bets on growing adult vaccine market | India News – Times of India

GSK Pharma bets on growing adult vaccine market | India News – Times of India

MUMBAI: British drug firm GlaxoSmithKline (GSK) is betting on power brands, innovative launches in adult vaccines, and a strong recovery in pediatric immunization, to grow double-digit in its key emerging market, India.
Armed with legacy brands — antibiotic Augmentin, pain and fever medication Calpol and skin ointment Betnovate, its Indian subsidiary, GSK Pharma plans to outperform the segments it has a presence in, and grow market share, the company’s managing director Bhushan Akshikar told TOI in an exclusive interview.
Besides following a “focus brand approach’’ on 10 -14 key drugs and vaccines, the company is now widening its portfolio of adult vaccines with the launch of shingles (herpes zoster) vaccine, Akshikar, who assumed the top job this month, said.
So far, GSK has focussed on mainly pediatric vaccines both in India and globally, but now hopes that the blockbuster shingles vaccine, Shingrix will play a key role.
“The COVID-19 vaccination drive has certainly started a conversation on adult vaccination and given it an impetus. We are a leader in paediatric vaccines and also have a strong adult vaccine portfolio in the country. With increased life expectancy and a growing segment of the elderly population, healthy aging is a big area of focus. A key intervention for healthy aging continues to be preventive health led by vaccination strategies. We currently market the flu vaccine- Fluarix for the elderly and pregnant women, and Boostrix- a DTP (diphtheria, pertussis and tetanus) booster vaccine recommended for pregnant women. We plan to maintain this position by introducing the new vaccine against shingles for adults in India, next year ’’, he said.
At present, GSK markets a range of pediatric vaccines which includes Infanrix Hexa, Havrix, Varilrix, Menveo, Boostrix, and Fluarix in the country. Equipped with more adult vaccines, the nearly Rs 3400-crore company expects the contribution of vaccines to increase over a three-four year period, from the existing 22% of the revenue.
Elaborating on prices, he said that the company will continue to operate in the private market, and intends to pursue a consistent “India pricing strategy’’.
“We anticipate the new shingles vaccine we aim to launch next year to significantly contribute to the company’s growth in addition to our existing brands’’, he added.
The shingles vaccine, which will be imported, is expected to be a premium-priced shot.
The shot was approved by India’s drug regulator recently, and will be launched for the 50-plus population next year. Clinical studies say that it provides protection for 10 years, according to the company.
Globally, GSK’s vaccines business recorded revenues of £2.5 billion in Q3 (July to September) 2022. Global revenues for the Shingles vaccine were up by over 50% to £760 million in the same period. The largest-selling vaccines for the drug biggie are for shingles, influenza and meningitis.

Source

Hits: 0

Leave a Reply

Your email address will not be published. Required fields are marked *

88 − = 82

Related Posts

Recent Posts

Raveena Tandon Reveals Why She Rejected Kuch Kuch Hota Hai, Says ‘Kajol Was My Contemporary’
Raveena Tandon Reveals Why She Rejected Kuch Kuch Hota Hai, Says 'Kajol Was My Contemporary'
CBSE Admit Card 2023: CBSE Class 10, 12 admit card released on cbse.gov.in, download now – Times of India
CBSE Admit Card 2023: CBSE Class 10, 12 admit card released on cbse.gov.in, download now - Times of India
RBI to issue norms to boost green finance, mitigate climate risks – Times of India
RBI to issue norms to boost green finance, mitigate climate risks - Times of India
Lebron James: NBA: Oklahoma City Thunder beat Los Angeles Lakers on LeBron James’ record night | More sports News – Times of India
Lebron James: NBA: Oklahoma City Thunder beat Los Angeles Lakers on LeBron James' record night | More sports News - Times of India
‘Smooch of the Union’: US first lady steals show with wayward kiss – Times of India
'Smooch of the Union': US first lady steals show with wayward kiss - Times of India
J-K Launches GPS-based Teachers’ Attendance App, to Seek Student Feedback on Their Performance
J-K Launches GPS-based Teachers' Attendance App, to Seek Student Feedback on Their Performance
OnePlus Featuring Keyboard 81 Pro launched with aluminium build and hot-swappable keycaps – Times of India
OnePlus Featuring Keyboard 81 Pro launched with aluminium build and hot-swappable keycaps - Times of India
Turkey: ‘Waiting for our dead’: Anger builds at Turkey’s earthquake response – Times of India
Turkey: 'Waiting for our dead': Anger builds at Turkey's earthquake response - Times of India
RBI projects inflation to fall to 5.3% in FY24 – Times of India
RBI projects inflation to fall to 5.3% in FY24 - Times of India
Salman Rushdie reveals what he looks like after knife attack – Times of India
Salman Rushdie reveals what he looks like after knife attack - Times of India

Archives

Categories

Tags

PHP Code Snippets Powered By : XYZScripts.com